![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Knapper Steven
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.20, Iss.10, 2011-10, pp. : 1377-1395
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Alvarado Yesid Kantarjian Hagop M. Luthra Rajyalakshmi Ravandi Farhad Borthakur Gautam Garcia-Manero Guillermo Konopleva Marina Estrov Zeev Andreeff Michael Cortes Jorge E.
Cancer, Vol. 120, Iss. 14, 2014-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Qu Shuang Liu Bin Guo Xiaoling Shi Hongshun Zhou Meifeng Li Li Yang Shulan Tong Xiuzhen Wang Haihe
Cancer, Vol. 120, Iss. 14, 2014-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
FLT3 as a Therapeutic Target in Childhood Acute Leukemia
Current Drug Targets, Vol. 8, Iss. 6, 2007-06 ,pp. :